Type 1 Diabetes: Pathogenesis and Prevention

Overview

Journal CMAJ

Date 2006 Jul 19

PMID 16847277

Citations 111

Authors

Kathleen M Gillespie

Affiliations

Soon will be listed here.

Abstract

Type 1 diabetes results from the autoimmune destruction of insulin-producing beta cells in the pancreas. Genetic and, as yet undefined, environmental factors act together to precipitate the disease. The excess mortality associated with the complications of type 1 diabetes and the increasing incidence of childhood type 1 diabetes emphasize the importance of therapeutic strategies to prevent this chronic disorder. Why is it considered that type 1 diabetes might be preventable? Different strands of diabetes research are coming together to suggest therapeutic targets. Islet cell autoantibody assays make it possible to accurately identify people at risk of future disease. In most cases, a long prodrome provides a window of opportunity to reverse the autoimmune process. Although no current "cure" exists, recent genetic data and preliminary trial results suggest T cells as a target for preventive strategies. Another potentially attainable target is induction of tolerance to the beta-cell proteins such as insulin that are inappropriately recognized. Other strategies involve beta-cell replacement, but currently there are insufficient donor cells available. This may be overcome as the processes controlling the differentiation of pancreatic and nonpancreatic progenitors as well as replication of existing islet beta cells are unravelled.

Citing Articles

A Network Pharmacology Study and In Vitro Evaluation of the Bioactive Compounds of Leaf Extract for the Treatment of Type 2 Diabetes Mellitus.

Wang Y, Cai S, Wen W, Tan Y, Wang W, Xu J Molecules. 2025; 30(5).

PMID: 40076380 PMC: 11901907. DOI: 10.3390/molecules30051157.

The immunoregulatory effects of scoparone on immune-mediated inflammatory diseases.

Qiu F, Lin J, Huang X, Yang B, Lu W, Dai Z Front Immunol. 2025; 16:1518886.

PMID: 39958341 PMC: 11825328. DOI: 10.3389/fimmu.2025.1518886.

Association between subtypes of diabetes and special sensations: A 2-sample Mendelian randomization study.

Liu S, Lei Z, Huang G, Zhang L, Luo W, Yang J Medicine (Baltimore). 2025; 104(5):e41332.

PMID: 39889175 PMC: 11789867. DOI: 10.1097/MD.0000000000041332.

Alcohol Consumption and Autoimmune Diseases.

Terracina S, Caronti B, Lucarelli M, Francati S, Piccioni M, Tarani L Int J Mol Sci. 2025; 26(2).

PMID: 39859557 PMC: 11766456. DOI: 10.3390/ijms26020845.

CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity.

Kong Y, Li J, Zhao X, Wu Y, Chen L Front Immunol. 2025; 15():1519671.

PMID: 39850899 PMC: 11754230. DOI: 10.3389/fimmu.2024.1519671.

References

Gale E, Bingley P, Emmett C, Collier T . European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet. 2004; 363(9413):925-31. DOI: 10.1016/S0140-6736(04)15786-3. View

Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M . A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004; 36(4):337-8. DOI: 10.1038/ng1323. View

Dor Y, Brown J, Martinez O, Melton D . Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004; 429(6987):41-6. DOI: 10.1038/nature02520. View

Eisenbarth G, Gottlieb P . Autoimmune polyendocrine syndromes. N Engl J Med. 2004; 350(20):2068-79. DOI: 10.1056/NEJMra030158. View

Burke G, Ciancio G, Sollinger H . Advances in pancreas transplantation. Transplantation. 2004; 77(9 Suppl):S62-7. DOI: 10.1097/01.tp.0000126929.71923.77. View

Seaberg R, Smukler S, Kieffer T, Enikolopov G, Asghar Z, Wheeler M . Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol. 2004; 22(9):1115-24. DOI: 10.1038/nbt1004. View

Nejentsev S, Cooper J, Godfrey L, Howson J, Rance H, Nutland S . Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes. 2004; 53(10):2709-12. DOI: 10.2337/diabetes.53.10.2709. View

Smyth D, Cooper J, Collins J, Heward J, Franklyn J, Howson J . Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 2004; 53(11):3020-3. DOI: 10.2337/diabetes.53.11.3020. View

Nerup J, Platz P, Andersen O, Christy M, LYNGSOE J, Poulsen J . HL-A antigens and diabetes mellitus. Lancet. 1974; 2(7885):864-6. DOI: 10.1016/s0140-6736(74)91201-x. View

10.

Cudworth A, Woodrow J . HL-A system and diabetes mellitus. Diabetes. 1975; 24(4):345-9. DOI: 10.2337/diab.24.4.345. View

11.

Bell G, Horita S, KARAM J . A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984; 33(2):176-83. DOI: 10.2337/diab.33.2.176. View

12.

Ginsberg-Fellner F, Witt M, Fedun B, TAUB F, Dobersen M, McEvoy R . Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis. 1985; 7 Suppl 1:S170-6. DOI: 10.1093/clinids/7.supplement_1.s170. View

13.

Feutren G, Papoz L, Assan R, Vialettes B, Karsenty G, Vexiau P . Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet. 1986; 2(8499):119-24. DOI: 10.1016/s0140-6736(86)91943-4. View

14.

Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D . Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature. 2005; 435(7039):220-3. PMC: 1364531. DOI: 10.1038/nature03523. View

15.

Kent S, Chen Y, Bregoli L, Clemmings S, Kenyon N, Ricordi C . Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature. 2005; 435(7039):224-8. DOI: 10.1038/nature03625. View

16.

Herold K, Gitelman S, Masharani U, Hagopian W, Bisikirska B, Donaldson D . A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes. 2005; 54(6):1763-9. PMC: 5315015. DOI: 10.2337/diabetes.54.6.1763. View

17.

Keymeulen B, Vandemeulebroucke E, Ziegler A, Mathieu C, Kaufman L, Hale G . Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005; 352(25):2598-608. DOI: 10.1056/NEJMoa043980. View

18.

Ryan E, Paty B, Senior P, Bigam D, Alfadhli E, Kneteman N . Five-year follow-up after clinical islet transplantation. Diabetes. 2005; 54(7):2060-9. DOI: 10.2337/diabetes.54.7.2060. View

19.

Atabani S, Thio C, Divanovic S, Trompette A, Belkaid Y, Thomas D . Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol. 2005; 35(7):2157-62. DOI: 10.1002/eji.200526168. View

20.

Gruessner A, Sutherland D . Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant. 2005; 19(4):433-55. DOI: 10.1111/j.1399-0012.2005.00378.x. View